Opiate mu-receptor ligands and pharmacotherapy of heroin dependence (CROSBI ID 527927)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | domaća recenzija
Podaci o odgovornosti
Sakoman, Slavko ; Jernej, Branimir
engleski
Opiate mu-receptor ligands and pharmacotherapy of heroin dependence
The treatment of opiate dependence is a complex and long term therapeutic problem. The most commonly used approach is transfer of dependent person to a prescription opioid medication, e.g., methadone, with long term maintenance. Alternative pharmacological therapy is the use ofd a specific narcotic antagonist naltrexone after detoxification. In detoxification procedure alpha-2 adrenergic agonist clonidine (aimed to compensate the loss of opioid suppression of the locus coeruleus system during the abstinence syndrome) is frequently used. However, detoxification is an approach applicable only to restricted population of patients. A new partial mu-receptor agonist and kappa-receptor antagonist buprenorphine (Subutex) represents a modern and safe therapeutic opinion.
opiate dependence; mu-receptor; detoxification
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
71-x.
2007.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Neurologia Croatica. Supplement
Hajnšek, S.
Zagreb: Medicinski fakultet Sveučilišta u Zagrebu
1331-5196
Podaci o skupu
The Second Croatian Congress of Neuroscience
poster
18.05.2007-19.05.2007
Zagreb, Hrvatska